|
Colorectal cancer mutation detection panel
January 2017
SHARING OPTIONS:
EntroGen
A highly multiplexed polymerase chain reaction (PCR)-based
assay for detection of common tumor-associated somatic mutations that provides prognostic and predictive markers for available treatments. This detection kit
enables simultaneous screening of 45 somatic mutations associated with colorectal cancer tumors in five oncogenes: KRAS, NRAS, BRAF, PIK3CA and AKT.
This comprehensive assay offers fast turnaround time of about two hours, ease of use and simplified analysis.
EntroGen’s Colorectal Cancer Mutation Detection Panel requires a real-time PCR instrument capable of detecting FAM, ROX, CY5 and VIC fluorescent
probes, and is now available for research use.
EntroGen
Back |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|